Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05270668 |
|---|---|
| Brief Title: | Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) (ATHENA-SSc-ILD) |
| First Submitted : | February 27, 2022 |
| First Submitted that Met QC Criteria : | March 7, 2022 |
| First Posted : | March 8, 2022 |
| Last Update Submitted that Met QC Criteria : | May 3, 2024 |
| Last Update Posted : | May 7, 2024 |